SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-15-017569
Filing Date
2015-03-20
Accepted
2015-03-20 17:15:26
Documents
7
Period of Report
2015-03-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v405128_8-k.htm 8-K 19504
2 EXHIBIT 10.1 v405128_ex10-1.htm EX-10.1 21557
3 EXHIBIT 10.2 v405128_ex10-2.htm EX-10.2 21514
4 EXHIBIT 10.3 v405128_ex10-3.htm EX-10.3 18255
5 EXHIBIT 10.4 v405128_ex10-4.htm EX-10.4 15943
6 EXHIBIT 10.5 v405128_ex10-5.htm EX-10.5 6897
7 EXHIBIT 10.6 v405128_ex10-6.htm EX-10.6 6884
  Complete submission text file 0001144204-15-017569.txt   112113
Mailing Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 619 BALTIMORE MD 21205 410-369-0365
CHAMPIONS ONCOLOGY, INC. (Filer) CIK: 0000771856 (see all company filings)

IRS No.: 521401755 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 000-17263 | Film No.: 15717051
SIC: 2836 Biological Products, (No Diagnostic Substances)